For individuals, friends and families who are looking to connect during life's challenging times. Share personal experiences, evaluate information and get support during times of need, illness, treatment or recovery.
Sponsored Links
Main Menu
Community
Treatment
Understand
- Where to Start
- What is Lymphoma?
- The Lymphatic System
- Lymphoma Symptoms
- Lymphoma Causes
- Lymphoma Prognosis
- Refractory/Relapsed Lymphoma
Non-Hodgkin's Lymphoma
Hodgkin's Disease
Surviving Lymphoma
Lymphoma and Pets
More
Seattle Genetics begins combination trial of SGN-35 plus ABVD
-
Call (877) 399-6937 or click here to learn more about Cancer Treatment options.
Seattle Genetics and Millennium Pharmaceuticals have announced the initiation of a Phase I multi-center clinical trial of their highly anticipated antibody-drug conjugate brentuximab vedotin in combination with the ABVD chemotherapy regimen, widely regarded as the gold standard in the treatment of Hodgkin's lymphoma.
Brentuximab vedotin (formerly known as SGN-35), which targets the CD30 protein on cancer cells, is currently in a trio of single-agent clinical trials:
- A clinical trial conducted under a Special Protocol Assessment (SPA) with the FDA for relapsed or refractory Hodgkin's lymphoma;
- A Phase II trial for relapsed or refractory systemic anaplastic large cell lymphoma;
- A Phase II retreatment trial for relapsed patients who previously responded to the therapy.
Additionally, a phase III relapse prevention trial is scheduled to be initiated by summer of 2010 for post-transplant Hodgkin's patients.
-
Call (877) 399-6937 or click here to learn more about Cancer Treatment options.
Support Groups
Find a Treatment Facility Near You
Click on a state below to find Lymphoma treatment options that could be right for you.
Select a State Below
- Alabama
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- Florida
- Georgia
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
The information provided on the Lymphoma Information Network is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational and educational purposes. The publication of this information does not constitute the practice of medicine, and this information does not replace the advice of your physician or other health care provider. Neither the owners or employees of LymphomaInfo.net nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.
Sponsored Links
LymphomaInfo Social
SupportGroups.com
SupportGroups.com provides a support network for those dealing with cancer and other life's challenges. Click on the following links to get the support in a confidential, caring environment.
Follow LymphomaInfo.net on:
Facebook:
Twitter: